Audio – FDA aims for rapid, not reckless, drug approvals

January 8, 2007


Dr. Andrew von Eschenbach,  in his first media interview since winning Senate confirmation, told the Reuters Regulation Summit that the U.S. Food and Drug Administration can improve its processes to assure the safety of medicines without slowing down new product reviews and approval.


No comments so far

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see